SPY338.33+3.44 1.03%
DIA279.93+2.43 0.88%
IXIC11,309.36+141.85 1.27%

Citigroup Maintains Buy on AbbVie, Raises Price Target to $105

Citigroup analyst Andrew Baum maintains AbbVie (NYSE:ABBV) with a Buy and raises the price target from $98 to $105.

· 09/02/2020 09:17
Citigroup analyst Andrew Baum maintains AbbVie (NYSE:ABBV) with a Buy and raises the price target from $98 to $105.